SCHEMBL10001570

SCHEMBL10001570

c1ccc(N(c2ccccc2)c2ccc(Nc3ccc4ccccc4c3)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.71
HSD17B10 Q99714 3/20 0.71
CYP3A4 P08684 3/20 0.71
HPGD P15428 1/20 0.71
SNCA P37840 1/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
HIF1A Q16665 1/20 0.46
CYP26A1 O43174 2/20 0.44
MAPT P10636 5/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALOX12 P18054 2/20 0.44
MAPK1 P28482 2/20 0.44
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28389125 0.96 ALDH1A1 (0.67) ALDH1A1HSD17B10CYP3A4HPGDSNCA
SCHEMBL4893481 0.96 ALDH1A1 (0.67) ALDH1A1HSD17B10CYP3A4HPGDSNCA
SCHEMBL27821843 0.96 ALDH1A1 (0.78) ALDH1A1HSD17B10CYP3A4HPGDSNCA
SCHEMBL3027645 0.96 ALDH1A1 (0.78) ALDH1A1HSD17B10CYP3A4HPGDSNCA
SCHEMBL16822402 0.96 ALDH1A1 (0.70) ALDH1A1HSD17B10CYP3A4HPGDSNCA
SCHEMBL12955830 0.93 ALDH1A1 (0.62) ALDH1A1HSD17B10CYP3A4HPGDSNCA
SCHEMBL14878705 0.93 ALDH1A1 (0.60) ALDH1A1HSD17B10CYP3A4HPGDSNCA
SCHEMBL12955885 0.92 ALDH1A1 (0.61) ALDH1A1HSD17B10CYP3A4HPGDSNCA
SCHEMBL12956012 0.91 ALDH1A1 (0.65) ALDH1A1HSD17B10CYP3A4HPGDSNCA
SCHEMBL23561391 0.91 ALDH1A1 (0.63) ALDH1A1HSD17B10CYP3A4HPGDSNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322673-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-12 US disclosed
US-20230322673-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-12 US disclosed
US-20220363637-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2022-11-17 US disclosed
EP-2383323-B1 NOVEL COMPOUNDS FOR AN ORGANIC PHOTOELECTRIC DEVICE, AND ORGANIC PHOTOELECTRIC DEVICE COMPRISING SAME CHEIL IND INC (KR) 2017-02-15 EP disclosed
US-8673460-B2 Heterocyclic derivative and organic light emitting device using same LG CHEM, LTD. (KR) 2014-03-18 US disclosed
US-8673460-B2 Heterocyclic derivative and organic light emitting device using same LG CHEM, LTD. (KR) 2014-03-18 US disclosed
US-8435648-B2 Pyridinylene ring compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode CHEIL INDUSTRIES, INC. (KR) 2013-05-07 US disclosed
US-20120161612-A1 NEW HETEROCYCLIC DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING SAME LG CHEM, LTD. (KR) 2012-06-28 US disclosed
US-20120161612-A1 NEW HETEROCYCLIC DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING SAME LG CHEM, LTD. (KR) 2012-06-28 US disclosed
EP-1926795-B1 NEW COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME(1) LG CHEMICAL LTD (KR) 2011-01-19 EP disclosed
WO-2007020804-A1 ARYLAMINE COMPOUND AND SYNTHETIC METHOD THEREOF SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-02-22 WO disclosed
US-20070037011-A1 Arylamine compound and synthetic method thereof SEMICONDUCTOR ENERGY LABORATORY CO. (JP) 2007-02-15 US disclosed
US-20070037011-A1 Arylamine compound and synthetic method thereof SEMICONDUCTOR ENERGY LABORATORY CO. (JP) 2007-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322673-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, CCNL2, CTNND1 ALDH1A1 1871/4885HSD17B10 3919/4885CYP3A4 1572/4885
US-20220363637-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, CCNL2, CTNND1 ALDH1A1 1871/4885HSD17B10 3919/4885CYP3A4 1572/4885
US-20070037011-A1 Arylamine compound and synthetic method thereof AHR, CYP2A13, ARNT ALDH1A1 502/4885HSD17B10 358/4885CYP3A4 45/4885
US-20120161612-A1 NEW HETEROCYCLIC DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING SAME PPOX, CYBA, NQO1 ALDH1A1 144/4885HSD17B10 1321/4885CYP3A4 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.